119 related articles for article (PubMed ID: 18559971)
21. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
22. Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats.
Toblli JE; Stella I; Mazza ON; Ferder L; Inserra F
Int J Impot Res; 2004 Aug; 16(4):305-12. PubMed ID: 15103316
[TBL] [Abstract][Full Text] [Related]
23. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
24. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE
Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
[TBL] [Abstract][Full Text] [Related]
25. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C
Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216
[TBL] [Abstract][Full Text] [Related]
26. Effect of rofecoxib on antihypertensive effects of candesartan in experimental models of hypertension.
Jain S; Gupta M; Malhotra S; Pandhi P
Methods Find Exp Clin Pharmacol; 2005; 27(1):11-6. PubMed ID: 15834454
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.
Alhusban A; Kozak A; Pillai B; Ahmed H; Sayed MA; Johnson MH; Ishrat T; Ergul A; Fagan SC
PLoS One; 2017; 12(6):e0178867. PubMed ID: 28640888
[TBL] [Abstract][Full Text] [Related]
28. Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats.
Brännström K; Morsing P; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S213-9. PubMed ID: 9892166
[TBL] [Abstract][Full Text] [Related]
29. [Effects of angiotensin II receptor antagonist on insulin sensitivity and sympathetic activity in spontaneously hypertensive rats].
Sasaki K; Kushiro T; Nakagawa S; Kanmatsuse K
Nihon Jinzo Gakkai Shi; 1999 Oct; 41(7):692-6. PubMed ID: 10572394
[TBL] [Abstract][Full Text] [Related]
30. Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat.
Stenman E; Jamali R; Henriksson M; Maddahi A; Edvinsson L
Eur J Pharmacol; 2007 Sep; 570(1-3):142-8. PubMed ID: 17597600
[TBL] [Abstract][Full Text] [Related]
31. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
[TBL] [Abstract][Full Text] [Related]
32. Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.
Soliman S; Ishrat T; Fouda AY; Patel A; Pillai B; Fagan SC
Transl Stroke Res; 2015 Aug; 6(4):309-22. PubMed ID: 26004281
[TBL] [Abstract][Full Text] [Related]
33. Pre-treatment with candesartan protects from cerebral ischaemia.
Ito T; Nishimura Y; Saavedra J
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
[TBL] [Abstract][Full Text] [Related]
34. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
35. Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control.
Toblli J; Stella I; Néstor Mazza O; Ferder L; Inserra F
Am J Hypertens; 2004 Jun; 17(6):516-22. PubMed ID: 15177525
[TBL] [Abstract][Full Text] [Related]
36. Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
Fogari R; Corradi L; Zoppi A; Lazzari P; Mugellini A; Preti P; Rinaldi A
Am J Hypertens; 2007 Oct; 20(10):1092-6. PubMed ID: 17903693
[TBL] [Abstract][Full Text] [Related]
37. The effect of recombinant aminopeptidase A on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan.
Ishii M; Hattori A; Numaguchi Y; Tsujimoto M; Ishiura S; Kobayashi H; Murohara T; Wright JW; Mizutani S
Horm Metab Res; 2008 Dec; 40(12):887-91. PubMed ID: 18726831
[TBL] [Abstract][Full Text] [Related]
38. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
[TBL] [Abstract][Full Text] [Related]
39. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
Wei F; Jia XJ; Yu SQ; Gu Y; Wang L; Guo XM; Wang M; Zhu F; Cheng X; Wei YM; Zhou ZH; Fu M; Liao YH;
Heart; 2011 Mar; 97(6):479-84. PubMed ID: 21296780
[TBL] [Abstract][Full Text] [Related]
40. Effects of up-titration of candesartan versus candesartan plus amlodipine on kidney function in type 2 diabetic patients with albuminuria.
Okura T; Kojima M; Machida H; Sugiyama M; Kato T; Komada T; Miyazaki T; Ninomiya T; Ichikawa T; Nakatani K; Watanabe Y; Dohi Y; Ito M; Kimura G
J Hum Hypertens; 2012 Apr; 26(4):214-9. PubMed ID: 21412266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
